UMIN ID: UMIN000061973
Registered date:20/06/2026
Prospective feasibility study of HYBRIDknifeflex-assisted gastric ESD using Gas-free Immersion and Flow-Assisted Coagulation
Basic Information
| Recruitment status | Pending |
|---|---|
| Health condition(s) or Problem(s) studied | Gastric adenoma and early gastric cancer indicated for endoscopic submucosal dissection (ESD) |
| Date of first enrollment | 2026/06/22 |
| Target sample size | 50 |
| Countries of recruitment | Japan |
| Study type | Interventional |
| Intervention(s) | Gastric ESD will be performed using HYBRIDknifeflex under the Gas-free Immersion (GFI) system. Flow-Assisted Coagulation (FAC) will be used for prophylactic coagulation and hemostasis when appropriate. The study prospectively evaluates the feasibility, safety, and procedural efficiency of this strategy. |
Outcome(s)
| Primary Outcome | Dissection speed (mm2min) |
|---|---|
| Secondary Outcome | 1. Procedure time 2. Resection time 3. Injection time 4. Hemostasis time 5. Number of intraoperative bleeding events 6. Total bleeding duration 7. Volume of injection solution 8. Number of hemostatic forceps uses 9. En bloc resection rate 10. R0 resection rate 11. Intraoperative perforation 12. Delayed bleeding 13. PECS 14. Aspiration pneumonia |
Key inclusion & exclusion criteria
| Age minimum | 20years-old |
|---|---|
| Age maximum | 100years-old |
| Gender | Male and Female |
| Include criteria | 1. Patients aged 20 to 100 years. 2. Patients with gastric adenoma, early gastric cancer, or gastric epithelial neoplasms suspected of early gastric cancer. 3. Patients judged to be indicated for gastric ESD according to clinical practice and relevant guidelines. 4. Patients scheduled to undergo gastric ESD during hospitalization. 5. Patients who provide written informed consent. |
| Exclude criteria | 1. Patients for whom surgical treatment is considered more appropriate. 2. Patients with severe comorbidities precluding safe endoscopic treatment or sedation. 3. Patients with severe coagulation disorders or other conditions that make ESD unsafe. 4. Pregnant women or patients suspected of being pregnant. 5. Patients judged inappropriate for participation by the investigators. |
Related Information
| Primary Sponsor | Suzuka General Hospital |
|---|---|
| Secondary Sponsor | |
| Source(s) of Monetary Support | None |
| Secondary ID(s) |
Contact
| public contact | |
| Name | Tatsuma Nomura |
| Address | Suzuka General Hospital, 1275-53, Yamanohana, Yasuduka, suzuka, Mie Japan 510-0235 |
| Telephone | 0593821311 |
| m06076tn@icloud.com | |
| Affiliation | Suzuka General Hospital Department of Gastroenterology |
| scientific contact | |
| Name | Tatsuma Nomura |
| Address | Suzuka General Hospital, 1275-53, Yamanohana, Yasuduka, suzuka, Mie Japan |
| Telephone | 09064948705 |
| m06076tn@icloud.com | |
| Affiliation | Suzuka General Hospital Department of Gastroenterology |